Search company, investor...

Compare Elevation Pharmaceuticals vs Neuraltus Pharmaceuticals

Customers evaluate the quality of Elevation Pharmaceuticals's products using the following success metrics.

Overview

Elevation Pharmaceuticals is based in United States

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company was founded in 2008 by Cam Garner, formerly Chairman and CEO of Dura Pharmaceuticals, Bill Gerhart, formerly President and CEO of Mpex Pharmaceuticals, and Ahmet Tutuncu, formerly VP of Medical Affairs at Verus Pharmaceuticals. The Company's initial focus is on developing novel drug products for the underserved subpopulation of COPD patients not able to effectively control their disease with dry powder or metered dose inhalers. In August 2012, Elevation Pharmaceuticals was acquired by Sunovion Pharmaceuticals. The valuation of Elevation Pharmaceuticals was $430 million. Other terms of the deal were not released.

Neuraltus Pharmaceuticals is based in United States

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physicians in the treatment of neurodegenerative diseases. The Company is collaborating with global ALS specialists and seeking input from patient advocacy organizations to help inform the clinical development path and better understand the needs of people affected by the disease.

Demo Video

Demo not available because Elevation Pharmaceuticals has not claimed their profile.

Work for Elevation Pharmaceuticals? Show off your product.

Demo not available because Neuraltus Pharmaceuticals has not claimed their profile.

Work for Neuraltus Pharmaceuticals? Show off your product.

Leadership

Bill Gerhart (Chief Executive Officer, President)

See all 4 people

Richard L Casey (Chief Executive Officer)

See all 5 people

Funding

Neuraltus Pharmaceuticals last raised $14.94M on 4/5/2016.

Investors

VantagePoint Capital Partners, Latterell Venture Partners

See all 4 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Elevation Pharmaceuticals has not claimed their profile.

Work for Elevation Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Elevation Pharmaceuticals?

Claim your profile now.

Information not available because Neuraltus Pharmaceuticals has not claimed their profile.

Work for Neuraltus Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Neuraltus Pharmaceuticals?

Claim your profile now.